AA
MNTA

AQR Arbitrage’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

AQR Arbitrage’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-773,269
Closed -$40.6M – 1234
2020
Q3 		$40.6M Buy
+773,269
New +$32M 1.47% 14

AQR Arbitrage's MNTA Position: Q4 2020 in Review

AQR Arbitrage sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 773,269 shares — an estimated $40.6M sold.

AQR Arbitrage first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $40.6M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • AQR Arbitrage reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • AQR Arbitrage sold 773,269 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $40.6M.
  • AQR Arbitrage first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • AQR Arbitrage's Momenta Pharmaceuticals, Inc. position peaked at $40.6M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on AQR Arbitrage's 13F filing for Q4 2020, filed 16 Feb 2021.